Pulmonary Division Chief, Department of Medicine, Jerold B. Katz Investigator

Previously, Folz was the chief of pulmonary critical care and sleep medicine at Cleveland Medical Center and a visiting professor at Case Western Reserve School of Medicine. Folz is a nationally recognized authority in pulmonary disease, specifically in the areas of lung disease following stem cell transplant, oxidative stress and older adults with asthma or chronic obstructive lung disease.

Carol Cockrell Curran Distinguished Centennial Chief in Hematologic Oncology, Dr. Mary and Ron Neal Cancer Center and Professor of Clinical Oncology

Previously, Ganguly was the A. Drue Jennings Endowed Professor of Medical Oncology at the University of Kansas Cancer Center, where he was also the deputy director of the division of hematological malignancies and cellular therapeutics, associate director of the blood and marrow transplantation program, and director of the lymphoma and myeloma program. His clinical and research interests include hematological malignancies, cellular therapeutics, and bone marrow transplantation.​

Chair, Department of Urology

Kobashi previously spent 22 years at Virginia Mason Medical Center, where she was a full-time urologist, head of the urology and renal transplantation service line at the main campus and five satellite clinics, founder and program director of the urology residency program and clinical fellowship program in Female Pelvic Medicine and Reconstructive Surgery (which attained ACGME accreditation) as well as director of the Pelvic Floor Center.

Research Assistant Professor of Cardiovascular Sciences

Before obtaining her current position, Li was an instructor in cardiovascular sciences at Houston Methodist.

Department of Radiology, PET Imaging Core

Lu was recruited from the University of Arizona, where he was a research professor of medical imaging in the clinical and translational oncology program at the University of Arizona Cancer Center. He has 30 years of research experience in nuclear medicine and molecular imaging, with a long track record of characterizing and developing molecular imaging probes for studying molecular events of human disease.

Dr. Mary and Ron Neal Cancer Center

Previously, Lu was an assistant professor of microbiology and immunology at the Wake Forest School of Medicine. His research focuses on tumor immunology, with a particular interest in T-cell-based and immune checkpoint-based cancer immunotherapy targeting melanoma, pancreatic cancer and breast cancer.

Dr. Mary and Ron Neal Cancer Center

Previously, Mathur was a postdoctoral researcher at the University of Dundee. Working at the chemistry/biology interface, Mathur is currently developing new probes for interrogating the behavior of ubiquitin system components. This can lead to advances such as the identification of novel therapeutic targets and the assignment E3 ligases to specific substrate.

Director, Center for Tissue Engineering, Department of Surgery

Nichols came from The University of Texas Medical Branch, where she served as the associate director of the Galveston National Laboratory and professor in the departments of internal medicine and microbiology and immunology. Nichols has held an affiliate appointment at Houston Methodist Research Institute since 2015. She is an expert in alterations in immune response of the lung after exposure to pollutants and/or respiratory pathogens and has expertise in the areas of general immunology, inflammation, disease pathogenesis, stem cell characterization/differentiation, wound healing, transplantation immunology, lung defense and respiratory pathogens.

Director of Patient Engagement, Diversity & Education, Department of Surgery; Division Chief for Patient Engagement and Diversity for the Center for Outcomes Research

Previously, Waterman was a professor in residence in the division of nephrology at UCLA, where she was also director of the Transplant Research and Education Center and director of the Terasaki Institute for Biomedical Innovation. Waterman’s interests center on further understanding the critical, modifiable patient-provider and system barriers to donation and designing interventions to overcome them.

Department of Pathology and Infectious Diseases

Previously, Panesso-Botero was an assistant professor at the University of Texas Health Science Center at Houston. Her research interests include drug-resistant bacterial infections.

Department of Pathology and Infectious Diseases

Previously, Tran was an associate professor in the division of infectious diseases, University of Texas Health Science Center at Houston. Her main areas of interest include antibiotic resistance and pharmacology. Through her work, Tran hopes to dissect antibiotic-associated pathways to provide insights into bacterial physiology that could be exploited with novel pharmacological strategies and translated to patient care.

Director, Center for Cancer Prevention, Dr. Mary and Ron Neal Cancer Center

You was recruited from the Medical College of Wisconsin, where he was the Joseph F. Heil Jr. Professor in Molecular Oncogenesis in the department of pharmacology and toxicology, associate provost for cancer research and founding director of the disease prevention research center. His research expertise is focused on the genetics and chemoprevention of lung cancer.